Fingerprint
Dive into the research topics of 'Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Umbrailisib and Duvelisib Clinical Trials'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Umbrailisib and Duvelisib Clinical Trials
Timothy Smith, Eli Paul, Griffin Hughes, Chase Ladd, Andriana Pena, Ryan McIntire, Brooke Gardner, Farzeen Syed, Jordan Tuia, Alyson Haslam, Vinay Prasad, Matt Vassar
Research output: Contribution to conference › Poster › peer-review
15
Downloads
(Pure)